about
Current Status: Site-Specific Antibody Drug ConjugatesAdvancement of Sialyltransferase Inhibitors: Therapeutic Challenges and OpportunitiesMetabolically incorporated photocrosslinking sialic acid covalently captures a ganglioside-protein complex.Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications.Effects of altered sialic acid biosynthesis on N-linked glycan branching and cell surface interactionsMetabolism of diazirine-modified N-acetylmannosamine analogues to photo-cross-linking sialosides.Abrogation of neuraminidase reduces biofilm formation, capsule biosynthesis, and virulence of Porphyromonas gingivalis.UDP-GlcNAc 2-Epimerase/ManNAc Kinase (GNE): A Master Regulator of Sialic Acid Synthesis.Multifarious roles of sialic acids in immunity.Carbohydrate engineered cells for regenerative medicine.Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogsDesigning a binding interface for control of cancer cell adhesion via 3D topography and metabolic oligosaccharide engineering.Tissue-based metabolic labeling of polysialic acids in living primary hippocampal neurons.Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug developmentBioorthogonal chemical reporter methodology for visualization, isolation and analysis of glycoconjugatesDeciphering glycan linkages involved in Jurkat cell interactions with gold-coated nanofibers via sugar-displayed thiols.Modified GM3 gangliosides produced by metabolic oligosaccharide engineeringDynamic Sialylation in Transforming Growth Factor-β (TGF-β)-induced Epithelial to Mesenchymal Transition.Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells.Sialidases as regulators of bioengineered cellular surfaces.Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: cytotoxicity, metabolic flux, and glycan-display considerationsSuccessful prediction of substrate-binding pocket in SLC17 transporter sialin.Metabolic flux increases glycoprotein sialylation: implications for cell adhesion and cancer metastasis.Cellular metabolism of unnatural sialic acid precursors.Nutrient-deprived cancer cells preferentially use sialic acid to maintain cell surface glycosylation.Fluorogenic sialic acid glycosides for quantification of sialidase activity upon unnatural substrates.Extracellular and intracellular esterase processing of SCFA-hexosamine analogs: implications for metabolic glycoengineering and drug delivery.Sialic acid metabolism and sialyltransferases: natural functions and applications.Photocrosslinking approaches to interactome mapping.Development of orally active inhibitors of protein and cellular fucosylationImaging beyond the proteomeMetabolic glycoengineering of mesenchymal stromal cells with N-propanoylmannosaminePreferential lectin binding of cancer cells upon sialic acid treatment under nutrient deprivationA Two-Photon Excitation Based Fluorogenic Probe for Sialome Imaging in Living Systems.Cell labeling and tracking method without distorted signals by phagocytosis of macrophages.Monitoring dynamic glycosylation in vivo using supersensitive click chemistryMetabolic oligosaccharide engineering: implications for selectin-mediated adhesion and leukocyte extravasation.Chemical tools to explore nutrient-driven O-GlcNAc cycling.Cell-Surface Glyco-Engineering by Exogenous Enzymatic Transfer using a Bi-Functional CMP-Neu5Ac Derivative.Residue-centric modeling and design of saccharide and glycoconjugate structures.
P2860
Q28829290-DB8858C4-D423-4E8D-A469-2F9E1EC23F33Q30039640-D699ED90-E07E-4D3C-A94C-2036819CA8A6Q33631331-5259DC38-2B5A-44C8-A6A2-71B963445B05Q33740696-07482451-AE7D-4DAF-82CD-D17F601B19C7Q33781368-F6C1BBCA-7CA7-4ADE-9038-D9D3A504988FQ33991792-4EE8273B-513C-41C3-AB83-8FBE2B4E99D7Q34057081-DD1437CB-C3D4-43C4-8815-B045F01E4522Q34167791-5F601DE5-8AF7-4569-9A5E-D32395731A12Q34270155-F68238F8-976E-45AB-8807-C7B6AB0E376AQ34545778-6F1ED821-BFC1-4F4E-869B-6ABD0724C5DBQ34573505-9B0C8738-9EFA-467E-80F6-AB873CF133A6Q35013793-8E916AEC-5F0D-4D63-BB5B-03039935DFDEQ35031519-F6D5D913-77A1-438E-B2A8-20E5A28C6CBDQ35105725-0990AA8A-4777-4232-B981-861AA141EAD6Q35123584-217CDE46-C626-431A-BA4E-C964BB7EB07CQ35165014-9E07C6B1-6299-48DC-ADD6-4C3158110438Q35165149-40F84EC0-1224-4F19-9E79-17334841083BQ35583066-02071830-370E-4BA9-9907-B91236F19AFDQ35615401-A0F0D62A-2364-4AB8-8135-EBA0271588B8Q35678457-0D49A0D5-B53E-4017-A804-2F6C92914590Q35785590-47F225A4-61A8-4E74-8882-2E62F2A68797Q35879473-8B33B6E9-5A6C-40EC-83CB-FEABA7754AEBQ36089893-50099B85-E28D-46D0-B5C7-091C3DFB995DQ36270708-6016A17B-90E5-4597-998A-11B27F283447Q36315969-7BE3B7B4-194D-48F0-966E-37930B0E8CE8Q36414548-3886971C-EBF0-40F2-AF65-395FA2A803A0Q36488687-3D7C0D11-5963-4E6B-B54A-2858255392BCQ36501918-ADFFF519-4E06-4654-B066-09D5FAF334C2Q36675377-E6356664-FD71-41BF-97D8-4B85C3A3853BQ36747458-66C0DD57-C693-4ED4-9F07-DD9AB0786239Q36862717-DBFC83BF-ACCE-40DA-A961-446C954608C5Q36964235-FEF3E57A-F258-4071-85BD-498625AEA26DQ37269017-38026661-7E1D-4750-BA6B-F5732D66B90BQ37309009-2C203BC1-E716-4341-B0FF-23E04A0EED00Q37605951-6A2D6EF7-E487-401B-A215-3D33A55139ABQ37714104-5F1FA0FD-8232-423A-93DF-3819BAF8C392Q37950862-CA273DAE-C412-428D-BEB2-5A4F9955CEB5Q38231368-AB75D1F9-22AC-4AFE-8769-D04DDCB3E9FEQ38287399-FD536218-D6E7-400F-BCF9-CB75B46C70A9Q38289968-DB11E2E0-8535-4392-AC15-CD932D47ABF8
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolic glycoengineering: sialic acid and beyond
@en
Metabolic glycoengineering: sialic acid and beyond.
@nl
type
label
Metabolic glycoengineering: sialic acid and beyond
@en
Metabolic glycoengineering: sialic acid and beyond.
@nl
prefLabel
Metabolic glycoengineering: sialic acid and beyond
@en
Metabolic glycoengineering: sialic acid and beyond.
@nl
P2093
P2860
P356
P1433
P1476
Metabolic glycoengineering: sialic acid and beyond
@en
P2093
Hargun S Khanna
Kevin J Yarema
Venkata D P Paruchuri
Zhiyun Wang
P2860
P304
P356
10.1093/GLYCOB/CWP115
P577
2009-08-12T00:00:00Z